Panoramic Tissue Examination That Integrates 3-Dimensional Pathology Imaging and Gene Mutation: Potential Utility in Non–Small Cell Lung Cancer

Schabath, 2019, Cancer progress and priorities: lung cancer, Cancer Epidemiol Biomarkers Prev, 28, 1563, 10.1158/1055-9965.EPI-19-0221 Barta, 2019, Global epidemiology of lung cancer, Ann Glob Health, 85, 8, 10.5334/aogh.2419 Luo, 2019, 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study, Lancet Oncol, 20, 1098, 10.1016/S1470-2045(19)30329-8 Wang, 2021, Toward personalized treatment approaches for non-small-cell lung cancer, Nat Med, 27, 1345, 10.1038/s41591-021-01450-2 Herbst, 2002, Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial, J Clin Oncol, 20, 3815, 10.1200/JCO.2002.03.038 Howlader, 2020, The effect of advances in lung-cancer treatment on population mortality, N Engl J Med, 383, 640, 10.1056/NEJMoa1916623 Kehl, 2020, Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era, Cancer Med, 9, 2019, 10.1002/cam4.2854 Doroshow, 2019, Immunotherapy in non-small cell lung cancer: facts and hopes, Clin Cancer Res, 25, 4592, 10.1158/1078-0432.CCR-18-1538 Lim, 2020, Immunotherapy for non-small cell lung cancer: current landscape and future perspectives, Immune Netw, 20, e10, 10.4110/in.2020.20.e10 Nasser, 2020, First line immunotherapy for non-small cell lung cancer, Pharmaceuticals (Basel), 13, 373, 10.3390/ph13110373 Reck, 2022, First-line immunotherapy for non-small-cell lung cancer, J Clin Oncol, 40, 586, 10.1200/JCO.21.01497 Xu, 2021, Challenges in advanced lung cancer diagnosis during the COVID-19 pandemic, Technol Cancer Res Treat, 20, 10.1177/15330338211050764 Ofiara, 2014, Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer, Front Oncol, 4, 253, 10.3389/fonc.2014.00253 Lee, 2019, Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy, Lab Invest, 99, 1400, 10.1038/s41374-018-0156-y Chen, 2019, Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues, Sci Rep, 9, 5624, 10.1038/s41598-019-41957-w Lin, 2022, Computer-assisted three-dimensional quantitation of programmed death-ligand 1 in non-small cell lung cancer using tissue clearing technology, J Transl Med, 20, 131, 10.1186/s12967-022-03335-5 Tanaka, 2017, Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity, Nat Biomed Eng, 1, 796, 10.1038/s41551-017-0139-0 Tainaka, 2016, Chemical principles in tissue clearing and staining protocols for whole-body cell profiling, Annu Rev Cell Dev Biol, 32, 713, 10.1146/annurev-cellbio-111315-125001 Zhu, 2019, Ultrafast optical clearing method for three-dimensional imaging with cellular resolution, Proc Natl Acad Sci U S A, 116, 11480, 10.1073/pnas.1819583116 Chiang, 2001, Three-dimensional mapping of brain neuropils in the cockroach, Diploptera punctata, J Comp Neurol, 440, 1, 10.1002/cne.1365 Collins, 2007, ImageJ for microscopy, Biotechniques, 43, 25, 10.2144/000112517 Ertürk, 2013, High-resolution imaging of entire organs by 3-dimensional imaging of solvent cleared organs (3DISCO), Exp Neurol, 242, 57, 10.1016/j.expneurol.2012.10.018 Cai, 2019, Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull-meninges connections, Nat Neurosci, 22, 317, 10.1038/s41593-018-0301-3 Lagerweij, 2017, Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment, Angiogenesis, 20, 533, 10.1007/s10456-017-9565-6 Marchetti, 2010, Effect of 1-alcohols on DNA condensation and protein folding, Chem Phys Lett, 493, 158, 10.1016/j.cplett.2010.05.014 Udovicić, 1996, Single-strand breaks in double-stranded DNA irradiated in anoxic solution: contribution of tert-butanol radicals, Radiat Res, 146, 198, 10.2307/3579591 Buranarom, 2021, Dichloromethane increases mutagenic DNA damage and transformation ability in cholangiocytes and enhances metastatic potential in cholangiocarcinoma cell lines, Chem Biol Interact, 346, 10.1016/j.cbi.2021.109580 Chu, 2021, Phase 1b study of sintilimab plus anlotinib as first-line therapy in patients with advanced NSCLC, J Thorac Oncol, 16, 643, 10.1016/j.jtho.2020.11.026 Yi, 2022, Combination strategies with PD-1/PD-L1 blockade: current advances and future directions, Mol Cancer, 21, 28, 10.1186/s12943-021-01489-2